Legend Biotech Company Leadership
LEGN Stock | USD 36.95 0.77 2.04% |
Legend Biotech employs about 2.6 K people. The company is managed by 20 executives with a total tenure of roughly 6067 years, averaging almost 303.0 years of service per executive, having 130.0 employees per reported executive. Analysis of Legend Biotech's management performance can provide insight into the firm performance.
Legend |
Legend Biotech's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Legend Biotech's future performance. Based on our forecasts, it is anticipated that Legend will maintain a workforce of about 2600 employees by April 2025.Legend Biotech Management Team Effectiveness
The company has return on total asset (ROA) of (0.1084) % which means that it has lost $0.1084 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1545) %, meaning that it created substantial loss on money invested by shareholders. Legend Biotech's management efficiency ratios could be used to measure how well Legend Biotech manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of March 2025, Return On Tangible Assets is likely to drop to -0.12. In addition to that, Return On Capital Employed is likely to drop to -0.33. At this time, Legend Biotech's Net Tangible Assets are very stable compared to the past year. As of the 22nd of March 2025, Other Current Assets is likely to grow to about 17.4 M, while Total Assets are likely to drop about 1.1 B.As of the 22nd of March 2025, Common Stock Shares Outstanding is likely to drop to about 156.9 M. In addition to that, Net Loss is likely to grow to about (381.6 M)
Legend Biotech Workforce Comparison
Legend Biotech Corp is rated second overall in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 15,664. Legend Biotech retains roughly 2,600 in number of employees claiming about 17% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.28) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.4) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.4. Legend Biotech Corp Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Legend Biotech Corp Price Series Summation is a cross summation of Legend Biotech price series and its benchmark/peer.
Legend Biotech Notable Stakeholders
A Legend Biotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Legend Biotech often face trade-offs trying to please all of them. Legend Biotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Legend Biotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Guowei Fang | President Development | Profile | |
Jessie MBA | Principal CFO | Profile | |
Elaine Qian | VP Resources | Profile | |
James JD | General Counsel | Profile | |
Lori CPA | Chief Officer | Profile | |
Birk Vanderweeen | Senior Supply | Profile | |
Tina Carter | Corporate Lead | Profile | |
Steven Gavel | US Development | Profile | |
Marc Harrison | VP Counsel | Profile | |
Liz Gosen | Senior Operations | Profile | |
Shu Wu | Senior China | Profile | |
Surabhi Verma | Manager Communications | Profile | |
Ying Huang | CEO Director | Profile | |
Yuhong Qiu | Senior Affairs | Profile | |
Doug Wallace | Vice Operations | Profile | |
Alan Kick | Senior Quality | Profile | |
Tim Roberts | Global Officer | Profile | |
Joanne Choi | Senior Relations | Profile | |
Deborah Wong | Executive Communications | Profile | |
Mythili MD | Chief Officer | Profile |
About Legend Biotech Management Performance
The success or failure of an entity such as Legend Biotech Corp often depends on how effective the management is. Legend Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Legend management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Legend management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.12) | (0.12) | |
Return On Capital Employed | (0.31) | (0.33) | |
Return On Assets | (0.11) | (0.11) | |
Return On Equity | (0.17) | (0.18) |
Legend Biotech Workforce Analysis
Traditionally, organizations such as Legend Biotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Legend Biotech within its industry.Legend Biotech Manpower Efficiency
Return on Legend Biotech Manpower
Revenue Per Employee | 241.2K | |
Revenue Per Executive | 31.4M | |
Net Loss Per Employee | 60.8K | |
Net Loss Per Executive | 7.9M | |
Working Capital Per Employee | 387K | |
Working Capital Per Executive | 50.3M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend Biotech Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96) | Revenue Per Share | Quarterly Revenue Growth 1.347 | Return On Assets | Return On Equity |
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.